4.7 Review

Impact of ERK5 on the Hallmarks of Cancer

Journal

Publisher

MDPI
DOI: 10.3390/ijms20061426

Keywords

ERK5; BMK1; MAPK7; MEK5; cancer; cell proliferation; invasion; metastasis; apoptosis; targeted therapy

Funding

  1. Associazione Italiana per la Ricerca sul Cancro [IG14184, IG 15282, IG21349]
  2. Institute for Cancer Research, Prevention and Clinical Network
  3. University of Florence

Ask authors/readers for more resources

Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. In recent years, accumulating lines of evidence point to a relevant role of ERK5 in the onset and progression of several types of cancer. In particular, it has been reported that ERK5 is a key signaling molecule involved in almost all the biological features of cancer cells so that its targeting is emerging as a promising strategy to suppress tumor growth and spreading. Based on that, in this review, we pinpoint the hallmark-specific role of ERK5 in cancer in order to identify biological features that will potentially benefit from ERK5 targeting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available